Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RPS7P14 (ribosomal protein S7 pseudogene 14) is a processed pseudogene in the human genome, named for its sequence similarity to the functional ribosomal protein S7 (RPS7) gene[2]. Pseudogenes do not encode functional proteins and are generally considered transcriptionally inactive, though in rare cases some may be transcribed into RNA. The functional RPS7 is a structural component of the eukaryotic ribosome’s 40S subunit and is essential for protein synthesis[3][6]. By contrast, RPS7P14 retains sequence similarity to RPS7 but is not known to participate in any therapeutic, enzymatic, or regulatory activity. It is not considered a drug target or a molecule of clinical interest. RPS7P14 is a pseudogene and not a functional protein or receptor. It does not serve as a therapeutic target. It does not interact with drugs, nor is it implicated in disease or biological pathways. The entry is primarily for genomic and evolutionary annotation rather than biomedical relevance[2][3][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein S7 pseudogene 14 (RPS7P14).